Get All The News

Dr. David G. Bostwick Returns as Chief Executive Officer of Bostwick Laboratories
- 8/18/2016

August 2016 - Bostwick Laboratories is pleased to announce that Bostwick Founder and Former Chief Executive Officer Dr. David G. Bostwick, MD, MBA, has returned to the role of Chief Executive Officer,...

Read More

Bostwick Laboratories is now in-network with UnitedHealthcare
- 10/2/2015

Effective October 1st, 2015, Bostwick Laboratories is now in-network with UnitedHealthcare.

This agreement brings Bostwick Laboratories’ CAP-accredited anatomic pathology labo...

Read More

Bostwick Laboratories to use Sienna reagent in world-first telomerase stain for bladder cancer launched today
- 1/9/2015

January 9, 2015 - Bostwick Laboratories, the USA’s leading uropathology laboratory has announced a commercial agreement with the Australian group, Sienna Cancer Diagnostics (Melbourne),...

Read More

MDxHealth and Bostwick Laboratories Announce Marketing Agreement for ConfirmMDx™ for Prostate Cancer
- 7/29/2013

Irvine, CA, Uniondale, NY and Liege, Belgium – 8:00 AM CET, July 29, 2013 – MDxHealth SA (NYSE Euronext: MDXH) and Bostwick Laboratories, Inc. today announced that they have e...

Read More

Bostwick Laboratories Hires Vice President of Sales
- 7/10/2013

Bostwick Laboratories announces the hiring of Robert Phillips as Vice President of Sales. Robert will lead the sales efforts for Bostwick Laboratories across all divisions and products.


Read More

Bostwick to Attend AUA's 2013 Annual Meeting
- 4/23/2013

Bostwick Laboratories will be exhibiting at the 2013 American Urological Association Annual Meeting, held on May 4-8 in San Diego, CA.  Read More

Dr. David G. Bostwick to Present Prostavysion and BladderVysion at AUA's 2012 Annual Meeting
- 4/26/2012

Dr. David G. Bostwick, CMO of Bostwick Laboratories, is slated to present on ProstaVysion and BladderVy...

Read More

Healthcare Finance Group, LLC Underwrites a $43.0 Million Financing Facility for Bostwick Laboratories, Inc.
- 7/7/2011

Glen Allen, VA - July 7, 2011 - Healthcare Finance Group, LLC (“HFG”) today announced that it has underwritten a $43 million Senior Secured Credi...

Read More

New Personalized Genetic Test- Prostavysion™ - Helps Prostate Cancer Patients Make Best Treatment Decisions
- 5/11/2011

Test Defines the Aggressiveness of Prostate Cancer

Richmond, VA - May 11, 2011 - Treatment of prostate cancer is often ...

Read More

Bostwick Laboratories Chooses XIFIN for Revenue Cycle Management
- 5/3/2011

Fast-Growing Anatomic Pathology Lab Leverages Advanced Technology Claims Management, Reporting and Analytics System

San Diego, C...

Read More
Displaying results 1-10 (of 32)
 |<  < 1 - 2 - 3 - 4  >  >|